Tahlil

Asetilkolin Reseptör Blocking Otoantikorları

Sanal Hastane||1 dk okuma
Asetilkolin Reseptör Blocking Otoantikorları

Klinik kullanımı :

Özellikle asetilkolin reseptör modulating antikoru pozitif olduğunda

Myastenia Gravis (MG) tanısında üçüncü sırada istenen analizdir.

Referans değerler

< 15 %

#Myastenia Gravis#Otoimmün hastalık

Kaynaklar ve Referanslar

  1. [1]Dresser L, Wlodarski R, Rezania K, et al. “Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations.”. Journal of clinical medicine. 2021. PMID: 34064035. PubMed →
  2. [2]Fichtner ML, Horstkorte L, Sanchez Navarro BG, et al.. “Autoantibodies in myasthenia gravis.”. International Review of Neurobiology. 2025. PMID: 40675742. PubMed →
  3. [3]Shuey NH. “Ocular myasthenia gravis: a review and practical guide for clinicians.”. Clinical & experimental optometry. 2022. PMID: 35157811. PubMed →
  4. [4]Kang SY, Oh JH, Song SK, Lee JS, Choi JC, Kang JH. “Both binding and blocking antibodies correlate with disease severity in myasthenia gravis.”. Neurological Sciences. 2015. PMID: 25964166. PubMed →
  5. [5]Pham MC, Masi G, Patzina R, et al. “Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology.”. Acta neuropathologica. 2023. PMID: 37344701. PubMed →
  6. [6]Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M. “Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.”. Clinical Chemistry. 1993. PMID: 8403390. PubMed →
Paylaş:
← Tüm Makaleler